Early Results of BetterLife Preclinical Study Show AP-003 (rhIFN⍺2b) Provides Up to 97% Protection in Human Cells Against the Delta Variant of SARS-CoV-2
October 12, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Oct. 12, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:NPAU ), an emerging biotech company focused on...
BetterLife Obtains TD-0148A Receptor Binding Data for IND-Enabling Pharmacology Studies
September 29, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Enrolls First Patient in Interferon alpha-2b COVID-19 Trial in Chile
September 22, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly owned...
BetterLife to Present at the Emerging Growth Conference on September 15, 2021
September 13, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotechnology company...
BetterLife Initiates Preclinical Study of AP-003 (rhIFNa2b) against Delta Variant of SARS-CoV-2
August 25, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotechnology company...
BetterLife Added to Horizons Psychedelic Stock Index ETF
March 29, 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has been added to the...
BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003
March 11, 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 11, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), today announced that its wholly-owned subsidiary, Altum...
BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies
March 08, 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 08, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development...
BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies
January 28, 2021 02:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and...